Restarting antiplatelet therapy about a month after #ICH deemed safe in this large, multicenter RCT. 21% reduction in point estimate for recurrent vascular events if restarted, but not significant (p=0.14). https://t.co/JML2ZkzT4v
#STROKE#ESOC2021 Real-world experience after #Alteplase to #Tenecteplase switch implementation in New Zealand showed #Tenecteplase is associated with better functional outcomes (mRS 0-2 OR=2.2) and shorter door-to-needle time @Anna_Ranta https://t.co/4oXIvdHq7x
Patients with recent stroke should not be treated routinely with 20 mg daily of #fluoxetine to prevent or treat post-stroke #depression during the first 6 months after the stroke https://t.co/OAesNuIbVU
ANGIOCAT clinical trial: Direct transfer to angiography suite increased the odds of undergoing EVT, reduced hospital workflow time and improved clinical outcome among patients with large vessel occlusion admitted in early window https://t.co/xkNczHGm6l
🔊 @jacquesmorcosmd said if I can get 100 likes/retweets he will let me clip his next open aneurysm case 🧠 . Help a neurosurgery brother out. Its like making the Super Bowl in your rookie year 🏈 . Also going to be a great session too @UMneurosurgery. #medtwitter#neurosurgery
In 106 clinical lacunar #stroke, automated CTP
maps sensitivity was 56.1% for cortical, 5.9% for subcortical, and 25% for posterior infarcts.
Role of Computed Tomography Perfusion in Identification of Acute Lacunar Stroke Syndromes https://t.co/aj9usAgsHt